Axa’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-82,480
Closed -$26.9M 107
2025
Q2
$26.9M Sell
82,480
-6,172
-7% -$1.71M 0.08% 229
2025
Q1
$23.9M Sell
88,652
-6,654
-7% -$1.71M 0.08% 243
2024
Q4
$22.4M Sell
95,306
-15,910
-14% -$4.18M 0.07% 253
2024
Q3
$30.6M Buy
111,216
+241
+0.2% +$62.7K 0.09% 214
2024
Q2
$27M Buy
110,975
+3,339
+3% +$527K 0.08% 228
2024
Q1
$16.1M Sell
107,636
-59,417
-36% -$9.91M 0.05% 322
2023
Q4
$32M Sell
167,053
-10,424
-6% -$1.78M 0.1% 203
2023
Q3
$31.4M Sell
177,477
-1,322
-0.7% -$252K 0.11% 191
2023
Q2
$34M Buy
178,799
+5,033
+3% +$998K 0.11% 198
2023
Q1
$34.8M Sell
173,766
-27,650
-14% -$5.81M 0.12% 201
2022
Q4
$47.9M Buy
201,416
+13,576
+7% +$2.9M 0.17% 143
2022
Q3
$37.6M Sell
187,840
-10,618
-5% -$2.03M 0.15% 160
2022
Q2
$28.9M Sell
198,458
-9,438
-5% -$1.34M 0.11% 225
2022
Q1
$33.9M Sell
207,896
-5,808
-3% -$885K 0.1% 242
2021
Q4
$36.2M Buy
213,704
+52,272
+32% +$9.72M 0.09% 246
2021
Q3
$30.5M Buy
161,432
+42,426
+36% +$7.96M 0.09% 261
2021
Q2
$20.2M Sell
119,006
-39,466
-25% -$5.78M 0.06% 345
2021
Q1
$22.4M Buy
158,472
+20,513
+15% +$3.09M 0.07% 326
2020
Q4
$17.9M Buy
137,959
+8,741
+7% +$1.17M 0.06% 357
2020
Q3
$18.8M Buy
129,218
+4,257
+3% +$605K 0.07% 298
2020
Q2
$18.5M Buy
124,961
+5,313
+4% +$716K 0.07% 279
2020
Q1
$13M Sell
119,648
-16,167
-12% -$1.87M 0.07% 307
2019
Q4
$15.6M Sell
135,815
-30,589
-18% -$3.05M 0.06% 350
2019
Q3
$13.4M Sell
166,404
-363
-0.2% -$28.7K 0.05% 389
2019
Q2
$12.1M Buy
166,767
+3,138
+2% +$241K 0.05% 421
2019
Q1
$15.3M Sell
163,629
-271
-0.2% -$22.7K 0.06% 360
2018
Q4
$11.9M Buy
163,900
+89,821
+121% +$6.91M 0.05% 389
2018
Q3
$6.48M Buy
+74,079
New +$7.45M 0.02% 599
2018
Q2
Sell
-1,884
Closed -$225K 1345
2018
Q1
$225K Buy
+1,884
New +$243K ﹤0.01% 1306
2017
Q4
Sell
-40,316
Closed -$4.74M 1347
2017
Q3
$4.74M Sell
40,316
-100,894
-71% -$8.61M 0.02% 640
2017
Q2
$11.3M Sell
141,210
-103,073
-42% -$6.59M 0.05% 392
2017
Q1
$12.5M Buy
244,283
+116,121
+91% +$5.37M 0.06% 355
2016
Q4
$4.8M Buy
128,162
+2,428
+2% +$102K 0.02% 593
2016
Q3
$8.52M Buy
125,734
+72
+0.1% +$5.08K 0.04% 447
2016
Q2
$6.97M Buy
125,662
+26,973
+27% +$1.7M 0.03% 492
2016
Q1
$6.2M Buy
98,689
+33,116
+51% +$2.2M 0.03% 501
2015
Q4
$6.17M Sell
65,573
-1,378
-2% -$128K 0.03% 502
2015
Q3
$5.38M Sell
66,951
-1,416
-2% -$157K 0.02% 548
2015
Q2
$8.2M Hold
68,367
0.03% 462
2015
Q1
$7.14M Buy
68,367
+4,830
+8% +$489K 0.03% 484
2014
Q4
$6.16M Buy
63,537
+4,065
+7% +$377K 0.02% 500
2014
Q3
$4.64M Buy
59,472
+33,403
+128% +$2.15M 0.02% 555
2014
Q2
$1.65M Sell
26,069
-1,048
-4% -$62.3K 0.01% 821
2014
Q1
$1.82M Buy
+27,117
New +$2.1M 0.01% 789

Other funds holding ALNY